Date:	August 30, 2016

To:	Brenda Shine, EPA/OAQPS/SPPD

From:	Jeff Coburn and Cassy Becker

Subject:	Meeting Record for August 25, 2016 meeting between
Representatives of TPA and Representatives of OAQPS (U.S. EPA)

On August 25, 2016, representatives of the U.S. Environmental Protection
Agency (EPA) and their contractor (RTI International) participated in a
meeting with representatives of Texas Pipeline Association (TPA). The
names and affiliations of the participants are included in Attachment 1.
The purpose of the meeting was to discuss the existing source oil and
gas information collection request (ICR) comments provided to the EPA by
TPA on August 2, 2016. TPA provided a brief introduction to their
association and the following topics were discussed.

Confidential Business Information (CBI). TPA representatives provided a
general overview of the gathering and boosting operations in Texas. They
explained that the midstream market is very competitive, both at the
receiving and providing ends of the gathering lines. TPA representatives
requested that either the entirety of the identity of the ICR-responding
company and the facility that is the subject of the ICR should be
protected so that no connection can be made between the data and the
company or facility at issue or, if not, EPA should significantly expand
the data elements that are considered to be CBI to provide additional
protections. TPA representatives noted that the ICR would provide a
convenient bundling of data that either was not previously available or
not collocated in one document before. They were concerned that
competitors, especially competitors that may not be selected to respond
to the ICR, would be able to use the information provided in the ICR to
gain an advantage over the responding companies. EPA representatives
indicated that the use of e-GGRT as a reporting tool for Part 2 of the
ICR would offer CBI protection for any data submitted.

CIPSEA. TPA representatives encouraged the use of Confidential
Information Protection and Statistical Efficiency Act of 2002 (CIPSEA)
in the collection of data under the ICR. They explained that CIPSEA
would protect the responding companies since any information provided
cannot be disclosed in an identifiable form and the information cannot
be used for any purpose other than a statistical purpose.

Miscellaneous. TPA representatives requested more time to respond to the
ICR. They also stated that the ICR burden estimate was low due to the
effort required for equipment counts.  EPA representatives replied that
best available data is being requested in the ICR, which should reduce
the burden and ease time constraints.

Attachment 1

Participants in August 25, 2016 EPA/TPA Meeting

TPA Representatives

Celina Romero, Duggins, Wren, Mann, & Romero, LLP

Jaron Hill, The Williams Companies, Inc.

Thure Cannon, TPA

Don Lewis, Duggins, Wren, Mann, & Romero, LLP

Eric Tiemeyer, Energy Transfer

Charles Yarbrough, Atmos

U.S. EPA Representatives

Angie Carey

Brenda Shine

Bruce Moore

Jonathan Witt

Penny Lassiter

Matthew Witosky

RTI International (EPA Contractor)

Jeff Coburn

Cassy Becker

 PAGE

 PAGE   2

  PAGE   \* MERGEFORMAT  2


[Federal Register Volume 86, Number 5 (Friday, January 8, 2021)]
[Notices]
[Pages 1504-1507]
[FR Doc No: 2021-00120]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. FDA-2018-N-3728]

Agency Information Collection Activities; Proposed Collection;
Comment Request; Collection of Information for Participation in the
Food and Drug Administration Non-Employee Fellowship and Traineeship
Programs

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA or Agency) is announcing
an opportunity for public comment on the proposed collection of certain
information by the Agency. Under the Paperwork Reduction Act of 1995
(PRA), Federal Agencies are required to publish notice in the Federal
Register concerning each proposed collection of information, including
each proposed extension of an existing collection of information, and
to allow 60 days for public comment in response to the notice. This
notice solicits comments on ``Collection of Information for
Participation in FDA Non-Employee Fellowship and Traineeship
Programs.''

DATES: Submit either electronic or written comments on the collection
of information by March 9, 2021.

ADDRESSES: You may submit comments as follows. Please note that late,
untimely filed comments will not be considered. Electronic comments
must be submitted on or before March 9, 2021. The https://www.regulations.gov electronic filing system will accept comments until
11:59 p.m. Eastern Time at the end of March 9, 2021. Comments received
by mail/hand delivery/courier (for written/paper submissions) will be
considered timely if they are postmarked or the delivery service
acceptance receipt is on or before that date.

Electronic Submissions

    Submit electronic comments in the following way:
     Federal eRulemaking Portal: https://www.regulations.gov.
Follow the instructions for submitting comments. Comments submitted
electronically, including attachments, to https://www.regulations.gov
will be posted to the docket unchanged. Because your comment will be
made public, you are solely responsible for ensuring that your comment
does not include any confidential information that you or a third party
may not wish to be posted, such as medical information, your or anyone
else's Social Security number, or confidential business information,
such as a manufacturing process. Please note that if you include your
name, contact information, or other information that identifies you in
the body of your comments, that information will be posted on https://www.regulations.gov.
     If you want to submit a comment with confidential
information that you do not wish to be made available to the public,
submit the comment as a written/paper submission and in the manner
detailed (see ``Written/Paper Submissions'' and ``Instructions'').

Written/Paper Submissions

    Submit written/paper submissions as follows:
     Mail/Hand Delivery/Courier (for written/paper
submissions): Dockets Management Staff (HFA-305), Food and Drug
Administration, 5630 Fishers Lane, Rm. 1061, Rockville, MD 20852.
     For written/paper comments submitted to the Dockets
Management Staff, FDA will post your comment, as well as any
attachments, except for information submitted, marked and identified,
as confidential, if submitted as detailed in ``Instructions.''
    Instructions: All submissions received must include the Docket No.
FDA-2018-N-3728 for ``Collection of Information for Participation in
FDA Non-Employee Fellowship and Traineeship Programs.'' Received
comments, those filed in a timely manner (see ADDRESSES), will be
placed in the docket and, except for those submitted as ``Confidential
Submissions,'' publicly viewable at https://www.regulations.gov or at
the Dockets Management Staff between 9 a.m. and 4 p.m., Monday through
Friday,<PHONE_NUMBER>.
     Confidential Submissions--To submit a comment with
confidential information that you do not wish to be made publicly
available, submit your comments only as a written/paper submission. You
should submit two copies total. One copy will include the information
you claim to be confidential with a heading or cover note that states
``THIS DOCUMENT CONTAINS CONFIDENTIAL INFORMATION.'' The Agency will
review this copy, including the claimed confidential information, in
its consideration of comments. The second copy, which will have the
claimed confidential information redacted/blacked out, will be
available for public viewing and posted on https://www.regulations.gov.
Submit both copies to the Dockets Management Staff. If you do not wish
your name and contact information to be made publicly available, you
can provide this information on the cover sheet and not in the body of
your comments and you must identify this information as
``confidential.'' Any information marked as ``confidential'' will not
be disclosed except in accordance with 21 CFR 10.20 and other
applicable disclosure law. For more information about FDA's posting of
comments to public dockets, see 80 FR 56469, September 18, 2015, or
access the information at: https://www.govinfo.gov/content/pkg/FR-2015-09-18/pdf/2015-23389.pdf.
    Docket: For access to the docket to read background documents or
the electronic and written/paper comments received, go to https://www.regulations.gov and insert the docket number, found in brackets in
the heading of this document, into the ``Search'' box and follow the
prompts and/or go to the Dockets Management Staff, 5630 Fishers Lane,
Rm. 1061, Rockville, MD 20852,<PHONE_NUMBER>.

FOR FURTHER INFORMATION CONTACT: Amber Sanford, Office of Operations,
Food and Drug Administration, Three White Flint North, 10A-12M, 11601
Landsdown St., North Bethesda, MD 20852,<PHONE_NUMBER>,
<EMAIL_ADDRESS>
SUPPLEMENTARY INFORMATION: Under the PRA (44 U.S.C. 3501-3521), Federal
Agencies must obtain approval from the Office of Management and Budget
(OMB) for each collection of information they conduct or sponsor.
``Collection of information'' is defined in 44 U.S.C. 3502(3) and 5 CFR
1320.3(c) and includes Agency requests or requirements that members of
the public submit reports, keep records, or provide information to a
third party. Section 3506(c)(2)(A) of the PRA (44 U.S.C. 3506(c)(2)(A))
requires Federal Agencies to provide a 60-day notice in the Federal
Register concerning each proposed collection of information, including
each proposed extension of an existing collection of information,
before submitting the collection to OMB for approval. To comply with
this requirement, FDA is publishing notice of the proposed collection
of information set forth in this document.
    With respect to the following collection of information, FDA
invites comments on these topics: (1) Whether the proposed collection
of information is necessary for the proper performance of FDA's
functions, including whether the information will have practical
utility; (2) the accuracy of FDA's estimate of the burden of the
proposed collection of information, including the validity of the
methodology and assumptions used; (3) ways to enhance the quality,
utility, and clarity of the information to be collected; and (4) ways
to minimize the burden of the collection of information on respondents,
including through the use of automated collection techniques, when
appropriate, and other forms of information technology.

Collection of Information for Participation in FDA Non-Employee
Fellowship and Traineeship Programs

OMB Control Number 0910--NEW

    In compliance with 44 U.S.C. 3507, FDA will submit to OMB a request
to review and approve a new collection of information: ``Collection of
Information for Participation in FDA Non-Employee Fellowship and
Traineeship Programs.'' Section 746(b) of the Federal Food, Drug and
Cosmetic Act (21 U.S.C. 379l(b)) allows FDA to conduct and support
intramural training programs through fellowship and traineeship
programs. These mandatory collection forms provide FDA with information
from the non-employee to: (1) Begin the program, (2) administer the
program, (3) coordinate training, and (4) end the program.
    1. To begin the program, the non-employee must submit the following
information: (A) New non-employee data form; (B) proof of health
insurance; (C) emergency contact information; (D) unified financial
management system (UFMS) supplier and site information for stipend
payments, financial information; and (E) CONCUR GOV New Traveler
Profile Form.
    (A) New non-employee data form to begin onboarding process--The New
Non-Employee Data form collects information that includes: (1) Name;
(2) gender; (3) birthplace; (4) date of birth; (5) email; (6) home
address; (7) FDA center/organization/supervisor; (8) citizenship; (9)
Social Security number (SSN); (10) start date; (11) end date; (12)
contract information; (13) location; and (14) question regarding
current or previous Federal work experience.
    (B) Proof of health insurance--Participants in FDA fellowship and
traineeship programs will be asked for certain information to
demonstrate proof of health insurance: (1) Name of health insurance
plan provider; (2) name/contact information of primary member; (3)
member identification number/group number; (4) begin date/policy
expiration date; and (5) signature. The purpose of the health insurance
information is for FDA to substantiate that participants of the program
are covered by health insurance.
    (C) Emergency contact information--Participants in FDA fellowship
and traineeship programs will be asked for certain information about
emergency contact demographics: (1) Name of fellow/trainee; (2) center;
(3) name of emergency contact; (4) telephone number of emergency
contact; and (5) relationship to contact. The purpose of emergency
contact information of fellows/trainees is to ensure there is a primary
contact should emergencies arise.
    (D) UFMS supplier and site information for stipend payments,
financial information--Participants in FDA fellowship and traineeship
programs will be asked for their financial institution routing number
and

account information for direct deposit of stipend payments: (1) Name;
(2) taxpayer ID or SSN; (3) classification/vendor type; (4) payment
options (electronic payment only); (5) mailing address; (6) bank/
financial institution information (name, routing number, account
number, account type); and (7) signature. The purpose of the financial
information is for FDA to process a direct deposit transaction for a
monthly stipend payment.
    (E) CONCUR GOV new traveler profile form--Participants in FDA's
non-employee scientist programs may be asked to travel and will need to
complete an online profile for the Concur Government Edition (CGE)
System, which requires the following information: (1) Personal
information (name, Agency, office/operating division, residence city,
residence state, signatures); (2) Agency information (ID #, title,
center accounting number); (3) business contact information; (4) email
addresses; emergency contact; (5) travel preferences (preferred
airline, hotel, airline seats, frequent flyer number); (6) credit card
number; (7) banking account for reimbursement; and (8) approving
signatures. The CGE profile provides assistance to travel preparers who
are booking travel for FDA program participants.
    2. To administer the program, non-employee scientists must submit
information for: (A) Absence recording form; (B) personal custody
property record; (C) FDA health summary; and (D) discovery and
invention.
    (A) Absence recording form--Participants in FDA fellowship and
traineeship programs will be asked for certain information about
tracking attendance and absences: (1) Name of fellow/trainee; (2)
office/division of placement; (3) mentor/sponsor name; (4) type of
absence; (5) dates of absence; (6) reason for absence; and (7) mentor/
sponsor approval. The purpose of tracking attendance and absences for
fellows/trainees is to determine the monthly stipend payment and
potential modifications to purchase orders for extended absences.
    (B) Personal custody property record--Participants in FDA
fellowship and traineeship programs will be required to sign the
property request, acknowledging personal responsibility for government
property. The plan collects the following information: (1) Fellow/
trainee name; (2) operative division/division; (3) location; (4)
telephone; (5) description of items; (6) items to be returned; (7)
return date; (8) fellow/trainee signature; (9) custodial officer
signature; and (10) issuing office. The purpose of this record is to
acknowledge that an individual has received government property and
accepts personal responsibility for items issued to perform their
roles.
    (C) FDA health summary--Participants in FDA fellowship and
traineeship programs will be asked for information about health for
laboratory activities. The FDA Occupational Health Services Health
Summary form collects information that includes: (1) Name; (2) program;
(3) email; (4) work phone; (5) FDA mentor; (6) center/office division;
(7) location; (8) date; (9) primary care physician and contact
information; (10) immunizations; (11) social history; (12) relationship
history; (13) allergies; and (14) medical history.
    (D) Discovery and invention--Participants in FDA fellowship and
traineeship programs will be asked for information about discoveries
and inventions at FDA. The discovery and invention report collects
information that includes: (1) Title of discovery; (2) description of
discovery; (3) identification of collaborators, cooperative research
and development agreement, and human materials or subjects; (4)
publications; (5) technology stage; (6) commercial potential; and (7)
competition, potential users, and manufacturers.
    3. For the coordination of training, non-employee scientists must
complete information for the: (A) Training development plan; (B) final
project report; (C) training request; (D) travel request; (E) Learning
Management System (LMS) request; (F) standard operating procedures
(SOP) verification; and (G) program evaluation.
    (A) Training development plan--Participants in FDA fellowship and
traineeship programs will be required to develop the individual plan in
partnership with their mentor. The plan collects the following
information: (1) Fellow/trainee name; (2) mentor(s)/preceptor(s) name;
(3) sign-on date; (4) year 1 goals, courses/training, regulatory
activities, and completion date; (5) year 2 goals, courses/trainings,
regulatory activities, and completion date; (6) fellow/trainee
signature; and (7) mentor(s)/preceptor(s) signature. The purpose of
this individual development/training plan is to have a record of
mandatory training and specific goals and tasks for the contributions
and/or completion of a project.
    (B) Final project report--Participants in FDA fellowship and
traineeship programs will be required to complete the final report in
partnership with their mentor. The plan collects the following
information: (1) Fellow/trainee name; (2) mentor/preceptor name; (3)
goals; (4) objectives; (5) alignment with center or FDA goals; (6)
project summary/abstract; (7) accomplishments; and (8) impact on public
health. The purpose of this report is to acknowledge the contributions
to the overall project and identify performance successes or
challenges. The collection of information is mandatory to participate
in FDA's fellowship and traineeship programs.
    (C) Training request--Participants in FDA fellowship and
traineeship programs will be asked to identify the following for
external training requests: (1) Name of fellow/trainee; (2) operating
office/staff division; (3) title and topic of training; (4) name of
hosting Agency/organization; (5) purpose/justification for external
training; (6) dates; (7) location; and (8) approving signatures. The
purpose of the external training request is to provide justification
substantiating the benefits to the operating office/staff division and/
or benefits to the fellow's/trainee's professional development and
training. The collection of information is mandatory to participate in
FDA's fellowship and traineeship programs.
    (D) Travel request--Participants in FDA fellowship and traineeship
programs will be asked for certain information about travel requests
and authorizations/approvals: (1) Office/division; (2) research project
title; (3) mentor/sponsor name; (4) mentor/sponsor email and telephone;
(5) fellow/trainee name; (6) appointment period; (7) funding source and
fiscal year; (8) brief description of travel; (9) anticipated travel
dates; and (10) travel justification and relation to project. The
purpose of authorization for travel of fellows/trainees is to determine
if the travel has been approved by the sponsor/mentor and if the travel
is a mission-related activity to the fellow/trainee training plan or
appointment/assignment. The collection of information is mandatory to
participate in FDA's fellowship and traineeship programs.
    (E) LMS access--Participants in FDA fellowship and traineeship
programs will be asked for information to obtain access to the LMS: (1)
Name; (2) location; (3) organizational unit; and (4) email address. The
purpose of LMS access request is to obtain information of non-employee
scientists to ensure they have access to receive training and
educational opportunities offered in the Health and Human Services LMS
System.
    (F) SOP verification--Participants in FDA fellowship and
traineeship programs will be asked for certain information to verify
that they have read and received instructional training on

the SOPs for said program. The form collects the following: (1) Name;
(2) signature; (3) date; and (4) center.
    (G) Program evaluation--Participants in FDA fellowship and
traineeship programs will be asked to complete an evaluation providing
program data that will be synthesized into program reports on the
overall effectiveness of the program. The evaluation collects the
following information: (1) Demographic data; (2) expectations of
fellowship or training program; (3) administration processes and
support to fellow or trainee; (4) FDA retention and plans of fellow or
trainee; (5) training and education completed; and (6) professional/
research goals. The purpose of this evaluation is to assess the
effectiveness of the program and feedback from participants to improve
the quality of the experience.
    4. To end the program, a non-employee must submit the exit
checklist--Participants in FDA fellowship and traineeship programs may
be asked to complete the exit checklist to manage the exit process and
return of FDA property. The exit checklist guides the exit process for
the following operational components: (1) Access key/pass; (2)
accountable property; (3) system applications inactive; (4) library
materials; (5) government-issued documents (i.e., passports); (6)
personal identity verification card/badge; (7) borrowed records; (8)
employee records; and (9) information technology accounts.
    All exit information will be entered to terminate access to any FDA
information.
    FDA estimates the burden of this collection of information as
follows:

                                                     Table 1--Estimated Annual Reporting Burden \1\
--------------------------------------------------------------------------------------------------------------------------------------------------------
                                                                 Number of
                  Activity                       Number of     responses per   Total annual           Average burden per response           Total hours
                                                respondents     respondent       responses
--------------------------------------------------------------------------------------------------------------------------------------------------------
New Non-Employee Data Form..................           1,220               1               1  0.25 (15 minutes).........................             305
Proof of Health Insurance...................             600               1               1  0.25 (15 minutes).........................             150
Emergency Contact Information...............           1,220               1               1  0.25 (15 minutes).........................             305
UFMS Supplier and Site Information for                   600               1               1  0.25 (15 minutes).........................             150
 Stipend Payments, Financial Information.
CONCUR GOV New Traveler Profile.............             620               1               1  0.25 (15 minutes).........................             155
Absence Recording Form......................           1,220               1               1  0.25 (15 minutes).........................             305
Personal Custody Property Record............           1,220               1               1  0.25 (15 minutes).........................             305
FDA Health Summary..........................           1,220               1               1  1.........................................           1,220
Discovery and Invention Form................           1,220               1               1  1.........................................           1,220
Training Development Plan...................           1,220               1               1  1.........................................           1,220
Final Project Report........................           1,220               1               1  1.........................................           1,220
Training Request............................             610               1               1  0.5 (30 minutes)..........................             305
Travel Request..............................             610               1               1  0.5 (30 minutes)..........................             305
LMS Access..................................           1,220               1               1  0.25 (15 minutes).........................             305
SOP Verification............................           1,220               1               1  0.25 (15 minutes).........................             305
Program Evaluation..........................           1,220               1               1  0.5 (30 minutes)..........................             610
Exit Checklist..............................           1,220               1               1  1.........................................           1,220
                                             -----------------------------------------------------------------------------------------------------------
    Total...................................           9,605
--------------------------------------------------------------------------------------------------------------------------------------------------------
\1\ There are no capital costs or operating and maintenance costs associated with this collection of information.

    FDA published a 60-day notice for this information collection on
November 22, 2019 (84 FR 64536). FDA is reopening the 60-day comment
period in order to satisfy PRA requirements. No changes have been made
to the information collection.

    Dated: January 4, 2021.
Lauren K. Roth,
Acting Principal Associate Commissioner for Policy.
[FR Doc. 2021-00120 Filed 1-7-21; 8:45 am]
BILLING CODE 4164-01-P


[Federal Register Volume 78, Number 113 (Wednesday, June 12, 2013)]
[Notices]
[Pages 35333-35334]
[FR Doc No: 2013-13888]

-----------------------------------------------------------------------

SECURITIES AND EXCHANGE COMMISSION

[Release No. 34-69708; File No. SR-FICC-2013-01]

Self-Regulatory Organizations; The Fixed Income Clearing
Corporation; Order Granting Approval of a Proposed Rule Change To Amend
the Mortgage-Backed Securities Division Rule To Reflect Recommendations
of the Treasury Market Practice Group

June 6, 2013.

I. Introduction

    On April 15, 2013, the Fixed Income Clearing Corporation (``FICC'')
filed with the Securities and Exchange Commission (``Commission'')
proposed rule change SR-FICC-2013-01 pursuant to Section 19(b)(1) of
the Securities Exchange Act of 1934 (``Act'') \1\ and Rule 19b-4
thereunder.\2\ The proposed rule change was published for comment in
the Federal Register on April 29, 2013.\3\ The Commission received no
comment letters. This order approves the proposed rule change.
---------------------------------------------------------------------------

    \1\ 15 U.S.C. 78s(b)(1).
    \2\ 17 CFR 240.19b-4.
    \3\ Securities Exchange Act Release No. 69424 (April 22, 2013),
78 FR 25115 (April 29, 2013).
---------------------------------------------------------------------------

II. Description

    To address the persistent settlement fails in agency debt and
mortgage-backed securities (``MBS'') transactions and to encourage
market participants to resolve such fails promptly, the Treasury Market
Practices Group (``TMPG'') recommended in February 2012 that the MBS
market impose a fails charge.\4\ FICC's Mortgage-Backed Securities
Division (``MBSD'') amended Rule 12 (Fails Charges) of MBSD's

Clearing Rules in March 2012 to reflect TMPG's recommendations.\5\ The
fails charge for MBS transactions applies to certain trades settled in
the MBSD central counterparty (``CCP'') (i.e., settlement of pools
versus FICC involving failing agency MBS issued or guaranteed by Fannie
Mae, Freddie Mac, and Ginnie Mae.) Consistent with the TMPG's initial
recommendation, MBSD's Rule 12 did not impose a fails charge if
delivery occurred on either of the two business days following the
contractual settlement date. The two business days are sometimes
referred to as the ``resolution period.''
---------------------------------------------------------------------------

    \4\ The TMPG is a group of market participants active in the
treasury securities market sponsored by the Federal Reserve Bank of
New York.
    \5\ See Securities Exchange Act Release No. 66550 (March 9,
2012), 77 FR 15155 (March 14, 2012) (File No. SR-FICC-2008-01).
---------------------------------------------------------------------------

    However, on March 1, 2013, the TMPG issued a new recommendation to
remove the two-day resolution period from the current practice.\6\ The
TMPG has advised that the revised recommendation should apply to
transactions in agency MBS transactions entered into on or after July
1, 2013, as well as to transactions that were entered into prior to but
remain unsettled as of July 1, 2013. This rule change amends the
existing fails charge rule to reflect TMPG's most recent recommendation
by removing the two-day resolution period provision from the rule.
Consequently, an agency MBS settlement fail will be subject to a fails
charge for each calendar day that the fail is outstanding, even if the
delivery occurs on either of the first two business days following the
contractual settlement date. FICC is making the rule change effective
as of July 1, 2013, in accordance with the TPMG's recommendation. All
other provisions of the agency MBS fails charge rule, including the
fails charge rate and trading practices, remain unchanged.
---------------------------------------------------------------------------

    \6\ Press Release, Federal Reserve Bank of New York, TMPG
Revises Agency MBS Fails Charge Trading Practice (March 1, 2013)
(available at www.newyorkfed.org/tmpg/03_01_2013_Fails_charges_press_release.pdf).
---------------------------------------------------------------------------

III. Discussion

    Section 19(b)(2)(C) of the Act \7\ directs the Commission to
approve a proposed rule change of a self-regulatory organization if it
finds that such proposed rule change is consistent with the
requirements of the Act and the rules and regulations thereunder
applicable to such organization. Section 17A(b)(3)(F) of the Act
requires, among other things, that the rules of a clearing agency be
designed to promote the prompt and accurate clearance and settlement of
securities transactions and to remove impediments to and perfect the
mechanism of a national system for the prompt and accurate clearance
and settlement of securities transactions.\8\ The Commission finds that
FICC's rule change should facilitate the prompt and accurate clearance
and settlement of securities transactions because the rule change will
discourage persistent settlement fails in agency debt and MBS
transactions and encourage market participants to resolve such fails
promptly.
---------------------------------------------------------------------------

    \7\ 15 U.S.C. 78s(b)(2)(C).
    \8\ 15 U.S.C. 78q-1(b)(3)(F).
---------------------------------------------------------------------------

IV. Conclusion

    On the basis of the foregoing, the Commission finds that the
proposed rule change is consistent with the requirements of the Act,
particularly with the requirements of Section 17A of the Act, and the
rules and regulations thereunder.
    It is therefore ordered, pursuant to Section 19(b)(2) of the
Act,\9\ that the proposed rule change (File No. SR-FICC-2013-01) be and
hereby is approved.\10\
---------------------------------------------------------------------------

    \9\ 15 U.S.C. 78s(b)(2).
    \10\ In approving this proposal, the Commission has considered
its impact on efficiency, competition, and capital formation. 15
U.S.C. 78c(f).

    For the Commission by the Division of Trading and Markets,
pursuant to delegated authority.\11\
---------------------------------------------------------------------------

    \11\ 17 CFR 200.30-3(a)(12).
---------------------------------------------------------------------------

Kevin M. O'Neill,
Deputy Secretary.
[FR Doc. 2013-13888 Filed 6-11-13; 8:45 am]
BILLING CODE 8011-01-P


[Federal Register: June 22, 2009 (Volume 74, Number 118)]
[Notices]
[Page 29525-29526]
[DOCID:fr22jn09-116]

-----------------------------------------------------------------------

SECURITIES AND EXCHANGE COMMISSION

[Release No. 34-60106; File No. SR-CBOE-2009-033]

Self-Regulatory Organizations; Chicago Board Options Exchange,
Incorporated; Notice of Filing of Proposed Rule Change Regarding
Statutory Disqualification Procedures

June 12, 2009.
    Pursuant to Section 19(b)(1) \1\ of the Securities Exchange Act of
1934 (the ``Exchange Act''),\2\ and Rule 19b-4 thereunder,\3\ notice is
hereby given that on May 26, 2009, the Chicago Board Options Exchange,
Incorporated (``CBOE'' or the ``Exchange'') filed with the Securities
and Exchange Commission (the ``SEC'' or ``Commission'') the proposed
rule change as described in Items I, II, and III below, which Items
have been substantially prepared by the Exchange. The Commission is
publishing this notice to solicit comments on the proposed rule change
from interested persons.
---------------------------------------------------------------------------

    \1\ 15 U.S.C. 78s(b)(1).
    \2\ 15 U.S.C. 78a.
    \3\ 17 CFR 240.19b-4.
---------------------------------------------------------------------------

I. Self-Regulatory Organization's Statement of the Terms of Substance
of the Proposed Rule Change

    The Exchange is proposing to amend its rule regarding members and
associated persons who are or become subject to a statutory
disqualification. The text of the proposed rule change is available on
the Exchange's Web site (http://www.cboe.org/legal), at the Exchange's
Office of the Secretary, and at the Commission's Public Reference Room.

II. Self-Regulatory Organization's Statement of the Purpose of, and
Statutory Basis for, the Proposed Rule Change

    In its filing with the Commission, the Exchange included statements
concerning the purpose of and basis for the proposed rule change and
discussed any comments it received on the proposed rule change. The
text of those statements may be examined at the places specified in
Item IV below. The Exchange has prepared summaries, set forth in
sections A, B, and C below, of the most significant parts of such
statements.

A. Self-Regulatory Organization's Statement of the Purpose of, and the
Statutory Basis for, the Proposed Rule Change

1. Purpose
    Exchange Rule 3.18(a) provides that the Exchange may determine not
to permit a member or an associated person of a member who is or
becomes subject to a statutory disqualification under the Exchange
Act,\4\ to continue in membership or in association with a member.
Under Rule 3.18(b), a member or an associated person who is or becomes
subject to a statutory disqualification and wishes to continue in
membership or in association with a member must submit an application
to the Exchange to do so. When the Exchange receives such an
application, or otherwise becomes aware that a member or an associated
person is subject to a statutory disqualification, the Exchange is
required to appoint a panel to conduct a hearing under the procedures
set forth in Rule 3.18 to determine whether to allow the member or
associated person to continue in membership or in association with a
member. The purpose of this rule filing is to expand the ability of the
Exchange to waive the requirement to conduct a hearing under Rule 3.18
if the Exchange intends to grant a member's application for continued
membership or an associated person's application for continued
association with a member.
---------------------------------------------------------------------------

    \4\ 15 U.S.C. 78a et seq.
---------------------------------------------------------------------------

    Exchange Act Rule 19h-1 \5\ prescribes the form and content of, and
establishes the mechanism by which the Commission reviews, proposals
submitted by self-regulatory organizations (``SROs''), such as the
Exchange, to allow a member or associated person subject to a statutory
disqualification to become or remain a member or associated with a
member. Among other things, Exchange Act Rule 19h-1 provides for
Commission review of notices filed by SROs proposing to admit any
person to, or continue any person in, membership or association with a
member, notwithstanding a statutory disqualification. However, Exchange
Act Rule 19h-1(a)(2) \6\ and Exchange Act Rule 19h-1(a)(3) \7\ provide
that for certain persons, and in limited circumstances, a notice does
not need to be filed.
---------------------------------------------------------------------------

    \5\ 17 CFR 240.19h-1.
    \6\ Exchange Act Rule 19h-1(a)(2), 17 CFR 240.19h-1(a)(2),
provides that a notice need not be filed with the Commission,
pursuant to Exchange Act Rule 19h-1, regarding an associated person
subject to a statutory disqualification if the person's activities
with respect to the member are solely clerical or ministerial in
nature and such person does not have access to funds, securities, or
books and records.
    \7\ Exchange Act Rule 19h-1(a)(3), 17 CFR 240.19h-1(a)(3),
provides that a notice need not be filed with the Commission,
pursuant to Exchange Act Rule 19h-1, regarding a person or member
subject to a statutory disqualification if the person or member
proposed for continued association or membership, respectively,
satisfies the requirements of Exchange Act Rule 19h-1(a)(3)(i)-(vi).
---------------------------------------------------------------------------

    Interpretation and Policy .03 to Rule 3.18 currently permits the
Exchange to waive the hearing provisions of Rule 3.18 when the Exchange
intends to grant an associated person's application for continued
association and the Exchange is not required to make a notice filing
with the Commission under Exchange Act Rule 19h-1(a)(2).\8\ The
Exchange is proposing to expand its ability to waive the hearing
provisions of Rule 3.18 to when the Exchange intends to grant a
member's or associated person's application for continued membership or
association and the Exchange is not required to make a notice filing
with the Commission under Exchange Act Rule 19h-1(a)(3).
---------------------------------------------------------------------------

    \8\ See Securities Exchange Act Release No. 56614 (October 4,
2007), 72 FR 58132 (October 12, 2007) (SR-CBOE-2007-14).
---------------------------------------------------------------------------

    The Exchange is also proposing to waive the hearing provisions of
Rule 3.18 when the Exchange determines to allow a member to continue in
membership, or an associated person to continue in association with a
member, and the Exchange determines that it is otherwise appropriate to
waive the hearing provisions of Rule 3.18 under the circumstances. For
example, a settlement agreement for a disciplinary matter involving
CBOE and multiple regulators or SROs could fully address statutory
disqualification issues, obviating the need for a CBOE hearing on those
same issues. The Exchange might also choose to exercise this waiver
authority when no regulatory purpose would be served by conducting a
hearing under Rule 3.18, such as when the Commission initiated the
proceeding regarding the underlying conduct that resulted in the
statutory disqualification and the sanction imposed in the matter does
not inhibit the applicable party's ability to continue as an Exchange
member or associated person.
    Interpretation and Policy .01 to Rule 3.18 (``Rule 3.18.01'')
provides that the Exchange may waive the provisions of Rule 3.18 when a
proceeding is pending before another SRO to determine whether to permit
a member or an associated person to continue in membership or
association with the

member notwithstanding a statutory disqualification. When the Exchange
exercises this waiver authority, Rule 3.18.01 currently provides that
the Exchange Department of Financial and Sales Practice Compliance
shall determine whether the Exchange will concur in any the Exchange
Act Rule 19h-1 filing made by another SRO. The Exchange is proposing to
make two clarifying changes to this provision. First, the Exchange
proposes to replace the reference to the ``Department of Financial and
Sales Practice Compliance'' with the ``Exchange'' because the Exchange
no longer has a department by that name. The Exchange is also proposing
to include the words ``member or'' in the last sentence of Rule 3.18.01
to clarify that the Exchange may concur in any Exchange Act Rule 19h-1
filing made by another SRO with respect to a member or an associated
person. This change is consistent with the rest of Rule 3.18.01.
2. Statutory Basis
    The Exchange believes the proposed rule change is consistent with
Section 6(b) of the Exchange Act,\9\ in general, and furthers the
objectives of Section 6(b)(5) of the Exchange Act,\10\ which requires,
among other things, that the Exchange's rules be designed to remove
impediments to and perfect the mechanism of a free and open market and
a national market system, and protect investors and the public
interest. The Exchange believes that the proposed rule change would
better enable the Exchange to streamline the administration of its
statutory disqualification program and better protect investors and the
public interest by focusing Exchange resources on circumstances
sufficient to warrant a statutory disqualification hearing.
---------------------------------------------------------------------------

    \9\ 15 U.S.C. 78f(b).
    \10\ 15 U.S.C. 78f(b)(5).
---------------------------------------------------------------------------

B. Self-Regulatory Organization's Statement on Burden on Competition

    CBOE does not believe that the proposed rule change will impose any
burden on competition that is not necessary or appropriate in
furtherance of the purposes of the Exchange Act.

C. Self-Regulatory Organization's Statement on Comments on the Proposed
Rule Change Received From Members, Participants, or Others

    No written comments were solicited or received with respect to the
proposed rule change.

III. Date of Effectiveness of the Proposed Rule Change and Timing for
Commission Action

    Within 35 days of the date of publication of this notice in the
Federal Register or within such longer period (i) as the Commission may
designate up to 90 days of such date if it finds such longer period to
be appropriate and publishes its reasons for so finding or (ii) as to
which the self-regulatory organization consents, the Commission will:
    (A) By order approve such proposed rule change, or
    (B) institute proceedings to determine whether the proposed rule
change should be disapproved.

IV. Solicitation of Comments

    Interested persons are invited to submit written data, views, and
arguments concerning the foregoing, including whether the proposed rule
change is consistent with the Exchange Act. Comments may be submitted
by any of the following methods:

Electronic Comments

     Use the Commission's Internet comment form (http://
www.sec.gov/rules/sro.shtml); or
     Send an e-mail to<EMAIL_ADDRESS>Please include
File Number SR-CBOE-2009-033 on the subject line.

Paper Comments

     Send paper comments in triplicate to Elizabeth M. Murphy,
Secretary, Securities and Exchange Commission, 100 F Street, NE.,
Washington, DC 20549-1090.

All submissions should refer to File Number SR-CBOE-2009-033. This file
number should be included on the subject line if e-mail is used. To
help the Commission process and review your comments more efficiently,
please use only one method. The Commission will post all comments on
the Commission's Internet Web site (http://www.sec.gov/rules/
sro.shtml). Copies of the submission, all subsequent amendments, all
written statements with respect to the proposed rule change that are
filed with the Commission, and all written communications relating to
the proposed rule change between the Commission and any person, other
than those that may be withheld from the public in accordance with the
provisions of 5 U.S.C. 552, will be available for inspection and
copying in the Commission's Public Reference Room, 100 F Street, NE.,
Washington, DC 20549, on official business days between the hours of 10
a.m. and 3 p.m. Copies of the filing will also be available for
inspection and copying at the principal office of CBOE. All comments
received will be posted without change; the Commission does not edit
personal identifying information from submissions. You should submit
only information that you wish to make available publicly. All
submissions should refer to File Number SR-CBOE-2009-033 and should be
submitted on or before July 13, 2009.

    For the Commission, by the Division of Trading and Markets,
pursuant to delegated authority.\11\
---------------------------------------------------------------------------

    \11\ 17 CFR 200.30-3(a)(12).
---------------------------------------------------------------------------

Florence E. Harmon,
Deputy Secretary.
[FR Doc. E9-14530 Filed 6-19-09; 8:45 am]

BILLING CODE 8010-01-P


[Federal Register Volume 86, Number 124 (Thursday, July 1, 2021)]
[Notices]
[Pages 35117-35118]
[FR Doc No: 2021-14085]

-----------------------------------------------------------------------

DEPARTMENT OF HOMELAND SECURITY

[Internal Agency Docket No. FEMA-4581-DR; Docket ID FEMA-2021-0001]

Colorado; Amendment No. 1 to Notice of a Major Disaster
Declaration

AGENCY: Federal Emergency Management Agency, DHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: This notice amends the notice of a major disaster declaration
for the State of Colorado (FEMA-4581-DR), dated January 15, 2021, and
related determinations.

DATES: This change occurred on June 7, 2021.

FOR FURTHER INFORMATION CONTACT: Dean Webster, Office of Response and
Recovery, Federal Emergency Management Agency, 500 C Street SW,
Washington, DC 20472,<PHONE_NUMBER>.

SUPPLEMENTARY INFORMATION: The Federal Emergency Management Agency
(FEMA) hereby gives notice that pursuant to the authority vested in the
Administrator, under Executive Order 12148, as amended, Alana B. Kuhn,
of FEMA is appointed to act as the Federal Coordinating Officer for
this disaster.
    This action terminates the appointment of Jon K. Huss, as Federal
Coordinating Officer for this disaster.

    The following Catalog of Federal Domestic Assistance Numbers
(CFDA) are to be used for reporting and drawing funds: 97.030,
Community Disaster Loans; 97.031, Cora Brown Fund; 97.032, Crisis
Counseling; 97.033, Disaster Legal Services; 97.034, Disaster
Unemployment Assistance (DUA); 97.046, Fire Management Assistance
Grant; 97.048, Disaster Housing Assistance to Individuals and
Households In Presidentially Declared Disaster Areas; 97.049,
Presidentially Declared Disaster Assistance--Disaster Housing
Operations for Individuals and Households; 97.050, Presidentially
Declared Disaster Assistance to Individuals and Households--Other
Needs; 97.036, Disaster Grants--Public Assistance (Presidentially
Declared Disasters); 97.039, Hazard Mitigation Grant.

Deanne Criswell,
Administrator, Federal Emergency Management Agency.
[FR Doc. 2021-14085 Filed 6-30-21; 8:45 am]
BILLING CODE 9111-23-P


[Federal Register: June 14, 2006 (Volume 71, Number 114)]
[Notices]
[Page 34401-34403]
[DOCID:fr14jn06-137]

-----------------------------------------------------------------------

SECURITIES AND EXCHANGE COMMISSION

[Release NO. 34-53950; File No. SR-Amex-2006-54]

Self-Regulatory Organizations; American Stock Exchange LLC;
Notice of Filing and Order Granting Accelerated Approval to a Proposed
Rule Change To Extend the Pilot Program for the Quote Assist Feature in
the ANTE System

June 6, 2006.
    Pursuant to section 19(b)(1) of the Securities Exchange Act of 1934
(``Act''),\1\ and Rule 19b-4 thereunder,\2\ notice is hereby given that
on May 23, 2006, the American Stock Exchange LLC (``Amex'' or
``Exchange'') filed with the Securities and Exchange Commission
(``Commission'') the proposed rule change as described in Items I and
II below, which Items have been substantially prepared by the Exchange.
The Commission is publishing this notice and order to solicit comments
on the proposed rule change from interested persons and to grant
accelerated approval to the proposed rule change.
---------------------------------------------------------------------------

    \1\ 15 U.S.C. 78s(b)(1).
    \2\ 17 CFR 240.19b-4.
---------------------------------------------------------------------------

I. Self-Regulatory Organization's Statement of the Terms of Substance
of the Proposed Rule Change

    The Exchange proposes to amend Amex Rule 958A--ANTE(e) to extend
until April 30, 2007, its pilot program implementing a quote-assist
feature in the Exchange's ANTE system (``Pilot Program'').
    The text of the proposed rule change is available at the Exchange's
Web site (http://www.amex.com/), the Exchange's principal office, and

the Commission's Public Reference Room.

II. Self-Regulatory Organization's Statement of the Purpose of, and
Statutory Basis for, the Proposed Rule Change

    In its filing with the Commission, the Exchange included statements
concerning the purpose of, and basis for, the proposed rule change and
discussed any comments it received on the proposed rule change. The
text of these statements may be examined at the places specified in
Item IV below. The Exchange has prepared summaries, set forth in
sections A, B, and C below, of the most significant aspects of such
statements.

A. Statement of the Purpose of, and Statutory Basis for, the Proposed
Rule Change

1. Purpose
    The purpose of the proposed rule change is to extend the Pilot
Program through April 30, 2007. The quote assist feature implemented
pursuant to the Pilot Program is intended to assist specialists on the
Exchange in meeting their obligations to display customer limit orders
immediately upon receipt.\3\ Amex Rule 958A--ANTE(e) requires all
option specialists to execute or display customer limit orders that
improve the bid or offer by price or size immediately upon receipt,
unless one of the exceptions set forth in the rule applies.
``Immediately upon receipt'' is defined in the rule as ``under normal
market conditions, as soon as practicable but not later than 30 seconds
after receipt.'' \4\
---------------------------------------------------------------------------

    \3\ See Amex Rule 958A--ANTE(e).
    \4\ See Amex Rule 958A--ANTE(e)(1).
---------------------------------------------------------------------------

    The quote assist feature implemented under the Pilot Program \5\
automatically displays eligible limit orders within a configurable time
that can be set on a class-by-class basis by the Exchange and the
specialist assigned to that class.\6\ While all customer limit orders
are expected to be displayed immediately, the specialist can set the
quote assist feature to automatically display limit orders at or close
to the end of the 30-second time frame--the maximum time frame
permitted by the rule--or within a shorter time frame established by
the Exchange. If the specialist fails to address the order within the
applicable display period, the quote assist feature will automatically
display the eligible customer limit order in the limit order book. The
quote assist feature helps to ensure that eligible customer limit
orders are displayed within the required time period.
---------------------------------------------------------------------------

    \5\ See Securities Exchange Act Releases No. 49747 (May 20,
2004), 69 FR 30344, 30347 (May 27, 2004) (approving implementation
of the ANTE system, including the quote assist feature on a pilot
basis); and No. 51955 (June 30, 2005), 70 FR 39812 (June 11, 2005)
(extending the Pilot Program until April 30, 2006).
    \6\ The time frame within which limit orders must be addressed--
a maximum of 30 seconds under the rule--may be set to a shorter time
period by the Exchange. The specialist maintaining the quote assist
feature may then use the feature to automatically display orders
within a shorter time period than the time period set by the
Exchange. Telephone conversation between Sudhir Bhattacharyya,
Assistant General Counsel, Amex, and Nathan Saunders, Special
Counsel, Division of Market Regulation, Commission, June 2, 2006.
---------------------------------------------------------------------------

    Rule 958A--ANTE (e)(4) requires the specialist to maintain and keep
active the limit order quote assist feature. The Specialist may
deactivate the quote assist feature provided Floor Official approval is
obtained. The specialist must obtain Floor Official approval as soon as
practicable but in no event later than three minutes after
deactivation. If the specialist does not receive approval within three
minutes after deactivation, the Exchange will review the matter as a
regulatory issue. Floor Officials will grant approval only in instances
when there is an unusual influx of orders or movement of the underlying
that would result in gap pricing or other unusual circumstances. The
Exchange will document all instances where a Floor Official has granted
approval.
    The Exchange notes that the quote assist feature does not relieve
the specialists of their obligation to display customer limit orders
immediately. To the extent that a specialist excessively relies on the
quote assist feature to display eligible limit orders without
attempting to address the orders immediately, the specialist could be
violating Rule 958A--ANTE (e). However, brief or intermittent reliance
on the quote assist feature by a specialist during an unexpected surge
in trading activity in an option class would not violate Rule 958A--
ANTE (e) if it occurs when the specialist is not physically able to
address all the eligible limit orders within the applicable time frame.
The Exchange has issued a regulatory notice discussing the issue of
excessive reliance on the quote assist feature.\7\
---------------------------------------------------------------------------

    \7\ See Amex Notice REG 2004-51, ``Rulings and Interpretations:
Limit Order Display Requirement in Options; Availability and
Deactivation of Quote Assist'' (December 8, 2004); see also Amex
Notice, ``Deactivation of Quote Assist'' (June 19, 2000) (both
available at http://www.amex.com/amextrader).

---------------------------------------------------------------------------

    The Exchange will continue to conduct surveillance to ensure that
specialists comply with their obligation to execute or book all
eligible limit orders within the time period prescribed by Exchange
rules. The Exchange commits to conduct surveillance designed to detect
whether specialists as a matter of course rely on the quote assist
feature to display all eligible limit orders. A practice of excessive
reliance upon the quote assist feature will be reviewed by Member Firm
Regulation as a possible violation of Rule 958A--ANTE (e). The Exchange
runs its limit order display exception report at various display
intervals in an attempt to detect a pattern that suggests undue
reliance on the quote assist feature. The Exchange reports to the
Commission every three months the statistical data it uses to determine
whether there has been impermissible reliance on the quote assist
feature by specialists.
2. Statutory Basis
    The proposed rule change is consistent with section 6(b) of the Act
\8\ in general and furthers the objectives of section 6(b)(5) of the
Act \9\ in particular in that it is designed to prevent fraudulent and
manipulative acts and practices, to promote just and equitable
principles of trade, and, in general, to protect investors and the
public interest.
---------------------------------------------------------------------------

    \8\ 15 U.S.C. 78f(b).
    \9\ 15 U.S.C. 78f(b)(5).
---------------------------------------------------------------------------

B. Statement of Burden on Competition

    The Exchange does not believe that the proposed rule change will
impose any burden on competition that is not necessary or appropriate
in furtherance of the purposes of the Act.

C. Comments on the Proposed Rule Change Received From Members,
Participants, or Others

    The Exchange has not solicited or received any written comments
regarding the proposed rule change.

III. Solicitation of Comments

    Interested persons are invited to submit written data, views, and
arguments concerning the foregoing, including whether the proposed rule
change is consistent with the Act. Comments may be submitted by any of
the following methods:

Electronic Comments

     Use the Commission's Internet comment form (http://www.sec.gov/rules/sro.shtml.
);     Send an e-mail to<EMAIL_ADDRESS>Please include

File Number SR-Amex-2006-54 on the subject line.

Paper Comments

     Send paper comments in triplicate to Nancy M. Morris,
Secretary, Securities and Exchange Commission, 100 F Street, NE.,
Washington, DC 20549-1090.

    All submissions should refer to File Number SR-Amex-2006-54. This
file number should be included on the subject line if e-mail is used.
To help the Commission process and review your comments more
efficiently, please use only one method. The Commission will post all
comments on the Commission's Internet Web site (http://www.sec.gov/rules/sro.shtml
). Copies of the submission, all subsequent amendments,

all written statements with respect to the proposed rule change that
are filed with the Commission, and all written communications relating
to the proposed rule change between the Commission and any person,
other than those that may be withheld from the public in accordance
with the provisions of 5 U.S.C. 552, will be available for inspection
and copying in the Commission's Public Reference Section. Copies of
such filing also will be available for inspection and copying at the
principal office of the Exchange. All comments received will be posted
without change; the Commission does not edit identifying personal
information from submissions. You should submit only information that
you wish to make available publicly. All submissions should refer to
file No. SR-Amex-2006-54 and should be submitted on or before July 5,
2006.

IV. Commission Findings and Order Granting Accelerated Approval of
Proposed Rule Change

    The Commission finds that the proposed rule change is consistent
with the requirements of the Act and the rules and regulations
thereunder applicable to a national securities exchange.\10\ In
particular, the Commission believes that the propose rule change is
consistent with the requirements of section 6(b)(5) of the Act,\11\
which requires, among other things, that the rules of the Exchange be
designed to promote just and equitable principales of trade and, in
general, to protect investors and the public interest.
---------------------------------------------------------------------------

    \10\ In approving the proposed rule, the Commission has
considered the rule's impact on efficiency, competition and capital
formation 15 U.S.C. 78c(f).
    \11\ 15 U.S.C. 78f(b)(5).
---------------------------------------------------------------------------

    The Commission believes that the quote assist feature should help
to ensure that eligible customer limit orders are displayed within the
required time period. The Commission notes that the Exchange represents
that it will continue to conduct surveillance to ensure that
specialists comply with their obligation to execute or book all
eligible limit order within the time period prescribed by Exchange
rules, and that they do not reply excessively on the quote assist
feature. Given this continuing surveillance, the Commission believes
that extending the Pilot Program is consistent with the Act.
    The Exchange has requested that the Commission approve the proposed
rule change prior to the thirtieth day after publication of notice of
the filing in the Federal Register. The commission believes that
accelerated approval is appropriate because it will enable the Pilot
Program to continue immediately. Accordingly, the Commission finds good
cause, consistent with section 19(b)(2) of the Act,\12\ to approve the
proposed rule change prior to the thirtieth day after publication of
the notice of filing thereof in the Federal Register.
---------------------------------------------------------------------------

    \12\ 15 U.S.C. 78s(b)(2).
---------------------------------------------------------------------------

V. Conclusion

    It is therefore ordered, pursuant to Section 19(b)(2) of the Act
\13\ that the proposed rule change (SR-Amex-2006-54) is hereby approved
on an accelerated basis.
---------------------------------------------------------------------------

    \13\ Id.

    For the Commission, by the Division of Market Regulation,
pursuant to delegated authority.\14\
---------------------------------------------------------------------------

    \14\ 17 CFR 200.30-3(a)(12).
---------------------------------------------------------------------------

Jill M. Peterson,
Assistant Secretary.
[FR Doc. 06-5369 Filed 6-13-06; 8:45 am]

BILLING CODE 8010-01-M


[Federal Register Volume 86, Number 55 (Wednesday, March 24, 2021)]
[Notices]
[Page 15666]
[FR Doc No: 2021-06014]

-----------------------------------------------------------------------

ENVIRONMENTAL PROTECTION AGENCY

[EPA-HQ-OLEM-10021-78-OLEM]

Brownfields Stakeholder Discussion and Listening Session With
Nonprofit Organizations and Community Foundations

AGENCY: Environmental Protection Agency (EPA).

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Environmental Protection Agency (EPA) will host an open
discussion and listening session with nonprofit organizations across
the country to hear about nonprofit leadership in brownfields
assessment, cleanup, and redevelopment projects. This is a virtual
event and will be held on Friday, April 23, 2021 through Zoom from 1
p.m.-3 p.m. Eastern Standard Time. EPA will make registration
information available to the public on the agency's website at http://www.epa.gov/brownfields on Friday, April 2, 2021. Due to the limit of
250 participants, attendance will be on a first-come, first served
basis. Registration is required. After registering and prior to April
2, confirmed participants will receive an email from Eventbrite with a
link to use to join the event.
    The purpose of this meeting is to hear from representatives of
nonprofits, using the following questions to guide the discussion: How
does your nonprofit organization view its role in brownfields cleanup
and redevelopment? What benefits and barriers exist to nonprofits
leading brownfield cleanup and redevelopment projects? How can EPA best
engage with nonprofit organizations that are most interested in leading
brownfields cleanup and redevelopment?
    In addition to the open discussion and listening session,
stakeholders may respond in writing to the guiding questions mentioned
above during a three-week comment period that will commence upon
publication of this notice. Comments will be accepted through April 23,
2021 and should be submitted through email to EPA's Office of
Brownfields and Land Revitalization at<EMAIL_ADDRESS>
DATES: This event will be held on April 23, 2021 through Zoom from 1
p.m.-3 p.m. Eastern Standard Time. Public comments submitted before the
event will be accepted through April 23, 2021 and should be submitted
through email to EPA's Office of Brownfields and Land Revitalization at
<EMAIL_ADDRESS>
FOR FURTHER INFORMATION CONTACT: Daniel Moher, U.S. EPA; email:
<EMAIL_ADDRESS>telephone:<PHONE_NUMBER>. Additional information
about EPA's Brownfields and Land Revitalization Program is available at
http://www.epa.gov/brownfields.

SUPPLEMENTARY INFORMATION: The Brownfields Utilization, Investment and
Local Development Act of 2018 (BUILD Act) amended the Brownfields
provisions of the Comprehensive, Environmental Response, Compensation
and Liability Act (CERCLA) to expand its eligibility for nonprofit
organizations. Nonprofits described as 501(c)(3), limited liability
corporations (LLCs) and community development agencies that are
nonprofit, can apply for multipurpose, assessment, cleanup, and
revolving loan fund grants.

A. Information About Services for Individuals With Disabilities or
Requiring English Language Translation Assistance

    For more information about accessibility or services for
individuals requiring assistance, please contact Daniel Moher, U.S.
EPA; email<EMAIL_ADDRESS>telephone:<PHONE_NUMBER>. To request
special accommodations for a disability, English language translation
or other assistance, please submit your request at least fourteen (14)
working days prior to the event to give EPA sufficient time to process
your request. All requests should be sent to the email or phone number
listed in the FOR FURTHER INFORMATION CONTACT section.

    Dated: March 18, 2021.
David Lloyd,
Director, Office of Brownfields and Land Revitalization.
[FR Doc. 2021-06014 Filed 3-23-21; 8:45 am]
BILLING CODE 6560-50-P


[Federal Register: March 15, 2010 (Volume 75, Number 49)]
[Notices]
[Page 12318]
[DOCID:fr15mr10-96]

=======================================================================
-----------------------------------------------------------------------

SECURITIES AND EXCHANGE COMMISSION

Sunshine Act Meeting

    Notice is hereby given, pursuant to the provisions of the
Government in the Sunshine Act, Public Law 94-409, that the Securities
and Exchange Commission will hold a Closed Meeting on Thursday, March
18, 2010 at 2 p.m.
    Commissioners, Counsel to the Commissioners, the Secretary to the
Commission, and recording secretaries will attend the Closed Meeting.
Certain staff members who have an interest in the matters also may be
present.
    The General Counsel of the Commission, or his designee, has
certified that, in his opinion, one or more of the exemptions set forth
in 5 U.S.C. 552b(c)(3), (5), (6), (7), 9(B) and (10) and 17 CFR
200.402(a)(3), (5), (6), (7), 9(ii) and (10), permit consideration of
the scheduled matters at the Closed Meeting.
    Commissioner Paredes, as duty officer, voted to consider the items
listed for the Closed Meeting in a closed session.
    The subject matter of the Closed Meeting scheduled for Thursday,
March 18, 2010 will be:
    Institution and settlement of injunctive actions;
    Institution and settlement of administrative proceedings;
    Collection matters;
    Consideration of amicus participation; and
    Other matters relating to enforcement proceedings.
    At times, changes in Commission priorities require alterations in
the scheduling of meeting items.
    For further information and to ascertain what, if any, matters have
been added, deleted or postponed, please contact:
    The Office of the Secretary at<PHONE_NUMBER>.

    Dated: March 11, 2010.
Florence E. Harmon,
Deputy Secretary.
[FR Doc. 2010-5728 Filed 3-11-10; 4:15 pm]
BILLING CODE 8011-01-P


[Federal Register Volume 81, Number 126 (Thursday, June 30, 2016)]
[Notices]
[Pages 42705-42706]
[FR Doc No: 2016-15567]

-----------------------------------------------------------------------

ENVIRONMENTAL PROTECTION AGENCY

[EPA-HQ-OECA-2012-0657; FRL-9946-31-OEI]

Information Collection Request Submitted to OMB for Review and
Approval; Comment Request; NSPS for Flexible Vinyl and Urethane Coating
and Printing (Renewal)

AGENCY: Environmental Protection Agency (EPA).

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Environmental Protection Agency has submitted an
information collection request (ICR), ``NSPS for Flexible Vinyl and
Urethane Coating and Printing (40 CFR part 60, subpart FFF) (Renewal)''
(EPA ICR No. 1157.11, OMB Control No. 2060-0073), to the Office of
Management and Budget (OMB) for review and approval in accordance with
the Paperwork Reduction Act (44 U.S.C. 3501 et seq.). This is a
proposed extension of the ICR, which is currently approved through June
30, 2016. Public comments were previously requested via the Federal
Register (80 FR 32116) on June 5, 2015, during a 60-day comment period.
This notice allows for an additional 30 days for public comments. A
fuller

description of the ICR is given below, including its estimated burden
and cost to the public. An Agency may not conduct or sponsor and a
person is not required to respond to a collection of information unless
it displays a currently valid OMB control number.

DATES: Additional comments may be submitted on or before August 1,
2016.

ADDRESSES: Submit your comments, referencing Docket ID Number EPA-HQ-
OECA-2012-0657, to: (1) EPA online using www.regulations.gov (our
preferred method), or by email to<EMAIL_ADDRESS>or by mail to:
EPA Docket Center, Environmental Protection Agency, Mail Code 28221T,
1200 Pennsylvania Ave. NW., Washington, DC 20460; and (2) OMB via email
to<EMAIL_ADDRESS>Address comments to OMB Desk Officer
for EPA.
    EPA's policy is that all comments received will be included in the
public docket without change, including any personal information
provided, unless the comment includes profanity, threats, information
claimed to be Confidential Business Information (CBI), or other
information whose disclosure is restricted by statute.

FOR FURTHER INFORMATION CONTACT: Patrick Yellin, Monitoring,
Assistance, and Media Programs Division, Office of Compliance, Mail
Code 2227A, Environmental Protection Agency, 1200 Pennsylvania Ave.
NW., Washington, DC 20460; telephone number:<PHONE_NUMBER>; fax
number:<PHONE_NUMBER>; email address<EMAIL_ADDRESS>
SUPPLEMENTARY INFORMATION:  Supporting documents which explain in
detail the information that the EPA will be collecting are available in
the public docket for this ICR. The docket can be viewed online at
www.regulations.gov or in person at the EPA Docket Center, WJC West,
Room 3334, 1301 Constitution Ave. NW., Washington, DC. The telephone
number for the Docket Center is<PHONE_NUMBER>. For additional
information about EPA's public docket, visit: http://www.epa.gov/dockets.
    Abstract: Owners and operators of affected facilities are required
to comply with reporting and recordkeeping requirements for the general
provisions of 40 CFR part 60, subpart A, as well as for the specific
requirements at 40 CFR part 60 subpart FFF. This includes submitting
initial notification reports, performance tests and periodic reports
and results, and maintaining records of the occurrence and duration of
any startup, shutdown, or malfunction in the operation of an affected
facility, or any period during which the monitoring system is
inoperative. These reports are used by EPA to determine compliance with
these standards.
    Form Numbers: None.
    Respondents/Affected Entities: Flexible vinyl and urethane coating
and printing facilities.
    Respondent's Obligation to Respond: Mandatory (40 CFR part 60,
subpart FFF).
    Estimated Number of Respondents: 25 (total).
    Frequency of Response: Initially and semiannually.
    Total Estimated Burden: 848 hours (per year). Burden is defined at
5 CFR 1320.3(b).
    Total Estimated Cost: $320,000 (per year), which includes $232,000
in both annualized capital/startup and operation & maintenance costs.
    Changes in the Estimates: There is an adjustment increase in the
respondent burden and cost, including total O&M cost, in this ICR. This
is not due to program changes; rather, it is due to an increase of one
additional source being subject to these regulations since the last ICR
renewal period. In addition, this ICR assumes all existing sources will
need to re-familiarize themselves with the regulation each year. This
change in assumption also contributes to an increase in the labor hours
and costs.

    Dated: June 23, 2016.
Matthew Leopard,
Director, Office of Information Collection.
[FR Doc. 2016-15567 Filed 6-29-16; 8:45 am]
 BILLING CODE 6560-50-P


[Federal Register: August 10, 2006 (Volume 71, Number 154)]
[Notices]
[Page 45801-45802]
[DOCID:fr10au06-34]

-----------------------------------------------------------------------

DEPARTMENT OF ENERGY

Federal Energy Regulatory Commission

[Docket No. EF06-2011-000]

U.S. Department of Energy, Bonneville Power Administration;
Notice of Filing

August 3, 2006.
    Take notice on July 28, 2006, Bonneville Power Administration (BPA)
tendered for filing proposed rate adjustments for its wholesale power
rates pursuant to section 7(a)(2) of the Pacific Northwest Electric
Power Planning and Conservation Act, 16 U.S.C. 839e(a)(2). BPA seeks
interim approval of its proposed rates effective September 29, 2006,
pursuant to Commission regulation 300.20, 18 CFR 300.20. Pursuant to
Commission regulation 300.21, 18 CFR 300.21, BPA seeks interim approval
and final confirmation of the proposed rates for the periods October 1,
2006, through September 30, 2009, for the following proposed wholesale
power rates:

PF-07 Priority Firm Power Rate.
NR-07 New Resource Firm Power Rate.
IP-07 Industrial Firm Power Rate.
FPS-07 Firm Power Products and Services Rate.

GTA General Transfer Agreement Delivery Charge.

    BPA also requests approval of the General Rate Schedule Provisions
(GRSPs) for the period of October 1, 2006, through September 30, 2009.
The GRSPs will apply to the 2006 wholesale power rates which include
the General Transfer Agreement Delivery Charge (GTA) which was approved
on a final basis, effective October 1, 2005, through September 30,
2007, by the Commission on September 29, 2005.
    Any person desiring to intervene or to protest this filing must
file in accordance with Rules 211 and 214 of the Commission's Rules of
Practice and Procedure (18 CFR 385.211, 385.214). Protests will be
considered by the Commission in determining the appropriate action to
be taken, but will not serve to make protestants parties to the
proceeding. Any person wishing to become a party must file a notice of
intervention or motion to intervene, as appropriate. Such notices,
motions, or protests must be filed on or before the comment date. On or
before the comment date, it is not necessary to serve motions to
intervene or protests on persons other than the Applicant.
    The Commission encourages electronic submission of protests and
interventions in lieu of paper using the ``eFiling'' link at http://www.ferc.gov.
 Persons unable to file electronically should submit an

original and 14 copies of the protest or intervention to the Federal
Energy Regulatory Commission, 888 First Street, NE., Washington, DC
20426.
    This filing is accessible online at http://www.ferc.gov, using the

``eLibrary'' link and is available for review in the Commission's
Public Reference Room in Washington, DC. There is an ``eSubscription''
link on the Web site that enables subscribers to receive E-mail
notification when a document is added to a subscribed docket(s). For
assistance with any FERC Online service, please E-mail
<EMAIL_ADDRESS>or call<PHONE_NUMBER> (toll free). For

TTY, call<PHONE_NUMBER>.
    Comment Date: 5 p.m. Eastern Time on August 28, 2006.

Magalie R. Salas,
Secretary.
[FR Doc. E6-13063 Filed 8-9-06; 8:45 am]

BILLING CODE 6717-01-P